Education
About Us
Working with TipRanks
Follow Us
Cerus Corporation (CERS)
:CERS
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.02Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Cerus Corporation's Q2 2025 earnings call highlights significant growth in product revenue, successful regulatory advancements, and strategic awards, indicating a strong business trajectory. However, there are challenges in China and potential regulatory changes in Germany that may pose risks.Company Guidance -
Q3 2025
Record Quarterly Sales and Revenue Guidance Increase
Cerus reported record product revenue of $52.4 million for Q2 2025, a 16% year-over-year increase. As a result, Cerus raised its full-year 2025 product revenue guidance to $200 million to $203 million from the previous range of $194 million to $200 million.
Strong U.S. and EMEA Growth
North American product revenues increased by 17% year-over-year, while EMEA product revenues rose by 21% compared to the same period last year, driven by strong platelet sales and expansion of plasma business.
Positive Non-GAAP Adjusted EBITDA
Cerus achieved its fifth consecutive quarter of positive non-GAAP adjusted EBITDA, totaling $935,000 for Q2 2025.
Progress in Regulatory Approvals and Product Launches
Cerus launched the INT200 Illuminator in Europe and received positive feedback. Additionally, the regulatory review for the red blood cell program in Europe is ahead of plan, with expected CE Mark approval in the second half of 2026.
Significant U.S. Defense Department Award
Cerus received a $7.2 million award from the U.S. Defense Department for a study evaluating the utility of IFC in trauma patients, indicating strong governmental support and potential for future applications.
CERS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CERS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $1.28 | $1.29 | +0.78% |
May 01, 2025 | $1.30 | $1.35 | +3.85% |
Feb 20, 2025 | $1.74 | $1.65 | -5.17% |
Oct 30, 2024 | $1.72 | $1.57 | -8.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cerus Corporation (CERS) report earnings?
Cerus Corporation (CERS) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Cerus Corporation (CERS) earnings time?
Cerus Corporation (CERS) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CERS EPS forecast?
CERS EPS forecast for the fiscal quarter 2025 (Q3) is -0.03.